Latest Regenerative medicine Stories
In a new study published by STEM CELLS Translational Medicine, scientists report on a way to produce natural cancer-killing cells in the lab in a quantity that could one day make them viable for treating patients. Durham, NC (PRWEB) March 20, 2013 In a new study published by STEM CELLS Translational Medicine, scientists report on a way to produce natural cancer-killing cells in the lab in a quantity that could one day make them viable for treating patients. While the production of human...
Ground-Breaking Clinical Trials Are Providing Families New Potential Treatment Options SAN BRUNO, Calif., March 19, 2013 /PRNewswire/ -- Cord Blood Registry® (CBR®), the world's largest newborn stem cell bank, is fueling innovation in newborn stem cell research. As CBR prepares to release its 250(th) cord blood unit for medical use this month, the newborn stem cell bank announces that 71% of all its units released for use have been for emerging applications in regenerative...
- Taking place April 17, 2013 in New York City; Agenda includes keynote talks, focused disease sessions with KOL participation and presentations from 16 top regenerative medicine companies - WASHINGTON, March 12, 2013 /PRNewswire/ -- The Alliance for Regenerative Medicine (ARM) today announced the agenda for its Regen Med Investor Day, the first investor event organized specifically for the regenerative medicine sector. The event will take place on April 17 at the Harmonie Club, 4...
WINSTON-SALEM, N.C., March 12, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that John L. Miclot, President and Chief Executive Officer of Tengion, will present at the upcoming 25th Annual ROTH Conference on Tuesday, March 19, 2013, at 2:00 p.m. PDT in Laguna Niguel, CA. A live audio webcast of the presentation can be accessed at http://wsw.com/webcast/roth27/tngn/ or under "Calendar of Events" in the Investors & News...
WINSTON-SALEM, N.C., March 11, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, March 18, 2013, at 9:00 a.m. EDT to provide a business update and discuss its fourth quarter and full year 2012 financial results. To participate in the call, please dial 1-866-543-6403 (domestic) or 1-617-213-8896 (international) and reference access code 98136968. The conference call...
The origin of beta-cells, the insulin-producing cells in the islets of Langerhans in the pancreas, has been controversial, and now new imaging and cell analysis technology shows that a recent study that seemed to have identified the progenitors of these important cells may have been in error, said researchers from Baylor College of Medicine, Texas Children’s Hospital and the University of Pennsylvania School of Medicine in Philadelphia. "This is a fundamental question for my field," said...
The Future of Regenerative Medicine: Dental Pulp Stem Cells and Dental Pulp Stem Cell Banking MIAMI, Florida (PRWEB) February 25, 2013 GeneCell International, a trusted provider in the processing and preservation of umbilical cord blood, today announced industry changing technologies in Honduras, via its affiliate, Drogueria Americana, that allow for the collection and storage of Dental Pulp Stem Cells, a type of multi-potent adult stem cell found in the pulp chamber of teeth, which show...
COVINA, Calif., Feb. 21, 2013 /PRNewswire/ -- StemCyte, Inc. proudly announces the endorsement of World and Olympic Champion United States gymnast, ovarian cancer survivor and mother, Shannon Miller. Shannon and her husband chose StemCyte to bank their first child Rocco's umbilical cord blood stem cells, and they are once again turning to StemCyte as they anticipate the arrival of their second child, this summer. Cord blood stem cells are potential cures for over 80...
Applications Include In Vitro Toxicology, Disease Models & Regenerative MedicineSingapore, Feb 21, 2013 - (ACN Newswire) - Researchers at the Institute of Bioengineering and Nanotechnology (IBN) have successfully generated human kidney cells from human embryonic stem cells in vitro(1). Specifically, they produced the renal cells under artificial conditions in the lab without using animals or organs. This has not been possible until now.According to IBN Executive...
BioMed Central Scientists have identified protein families expressed during tissue regeneration in newts, providing the groundwork for research into whether particular sets of genes are used for the purpose. The transcriptome – the map of all RNA molecules – of the newt is published this week in BioMed Central's open access journal Genome Biology. Notophthalmus viridescens is a useful model in regenerative medicine, thanks to its ability to regenerate tissue, and this data gives...
